STOK - Stoke Therapeutics, Inc.
IEX Last Trade
11.41
-0.020 -0.175%
Share volume: 7,377
Last Updated: Thu 26 Dec 2024 08:30:20 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$11.43
-0.02
-0.17%
Summary score
24%
Profitability
25%
Dept financing
7%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.16%
Return on assets
-9.26%
Return on sales
-1921.27%
Return on invested capital
356.2%
Total debt ratio
17.23%
Debt ratio change over timeo
-0.9%
Current Ratio
17.69%
Quick Ratio
17.69%
Cash Position Ratio
17.06%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.5%
Return on assets
-12.8%
Return on sales
-3839.16%
Return on invested capital
174.42%
Total debt ratio
28.89%
Debt ratio change over timeo
-0.83%
Current Ratio
8.21%
Quick Ratio
8.21%
Cash Position Ratio
7.67%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-18.79%
Return on assets
-13.83%
Return on sales
-672.96%
Return on invested capital
111.36%
Total debt ratio
31.6%
Debt ratio change over time
-0.79%
Current Ratio
5.43%
Quick Ratio
5.43%
Cash Position Ratio
5.02%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.77%
Return on assets
-104.67%
Return on sales
-1670.29%
Return on invested capital
21.2%
Total debt ratio
-89.96%
Debt ratio change over time
-0.9%
Current Ratio
5.11%
Quick Ratio
5.11%
Cash Position Ratio
4.85%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | STOK | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.16% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.26% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1921.27% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 356.2% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 59% | 57% |
| Total debt ratio | 17.23% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.9% | 308.97% | -6.99% | 1.18% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 8.21% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.21% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.67% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 6% | 15% |
| Short-term ratios | STOK | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.5% | 13.77% | 13.25% | 3.8% |
| Return on assets | -12.8% | 2.43% | 1.89% | 3.09% |
| Return on sales | -3839.16% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 174.42% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 58% |
| Total debt ratio | 28.89% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.83% | 46.38% | -72.08% | 1.51% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 8.21% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.21% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 7.67% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 6% | 16% | 40% |